Public Health

Is Evidence-Based Medicine Built on a Flawed Foundation?
Clinical & Pharma Is Evidence-Based Medicine Built on a Flawed Foundation?

A significant critique with far-reaching implications for medical research and clinical practice has exposed profound methodological flaws in a widely referenced meta-analysis, igniting an urgent conversation about the very bedrock of modern healthcare. The research, conducted by K. Pai, A. Raghav,

Predicting Outbreaks by Understanding Seasonal Cycles
Clinical & Pharma Predicting Outbreaks by Understanding Seasonal Cycles

Infectious diseases often follow a surprisingly predictable calendar, with outbreaks of illnesses like influenza and dengue fever recurring at the same time each year like clockwork. This phenomenon is driven by seasonal epidemiology cycles, which are the rhythmic fluctuations in disease

Cuba Battles Deadly Dengue and Chikungunya Crisis
Clinical & Pharma Cuba Battles Deadly Dengue and Chikungunya Crisis

A severe public health emergency is unfolding across Cuba as the nation grapples with a dual outbreak of dengue and chikungunya, two debilitating mosquito-borne illnesses that have overwhelmed healthcare systems and claimed dozens of lives. The province of Sancti Spíritus has emerged as a major

HMRI Honors Top Innovators in Medical Research
Clinical & Pharma HMRI Honors Top Innovators in Medical Research

In a year marked by significant advancements in health and medicine, the Hunter Medical Research Institute recently gathered to celebrate the individuals and teams whose pioneering work is shaping the future of healthcare at the 2025 HMRI Research Excellence Awards. The prestigious annual gala,

How Is Kennedy Reshaping America’s Health Department?
Clinical & Pharma How Is Kennedy Reshaping America’s Health Department?

As we sit down with Dr. James Maitland, a seasoned expert in public health policy and communications, we’re diving into a critical moment for the U.S. Department of Health and Human Services (HHS) under Robert F. Kennedy Jr.’s leadership. With decades of experience analyzing how health messaging

What Drives the Opioid-Induced Constipation Market to 2034?
Clinical & Pharma What Drives the Opioid-Induced Constipation Market to 2034?

Imagine a patient struggling with chronic pain, finally finding relief through opioid therapy, only to be sidelined by a side effect so severe it disrupts their daily life—constipation that won’t budge. This condition, known as Opioid-Induced Constipation (OIC), affects millions globally, stemming

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later